>> WELCOME TO NEW HAMPSHIRE'S
BUSINESS.
I'M FRED KHOBAR.
THIS IS THE MEDICAL INDEX.
LOOK AT THE FAR LEFT, OVER TO
2016.
AND THE INCREASE IN COSTS OF THE
ANNUAL MEDICAL COSTS FOR A
FAMILY OF FOUR, FOR THE FIRST
TIME IN THIS COUNTRY, IT HAS
SURPASSED $25,000.
THAT'S THE INTRODUCTION TO MY
INTERVIEW AND THE INTERRUE IS
ABOUT A STUDY THAT'S BEEN DONE
BY TWO NEW HAMPSHIRE CAN'T IN
TANDEM.
A REPEAT PATIENT MONITORING
STUDY, AT HOME STUDY OF
HARRISBURG BLUE CROSS MEMBERS.
AND THE STUDY AT MANCHESTER AND
MEDTRONICS OF PORTSMOUTH.
INCLUDING PERSONALIZED HEALTH
CARE PLANNING.
NOW, THEIR FINDINGS ARE
SIGNIFICANT.
THEY FOUND SAVINGS OF 8,375
DOLLARS ANNUALLY FOR CHARGE
HEALTH PLANS THAT COULD SAVE
MILLIONS DUE TO ACUTE ADMISSIONS
AND FEWER THAN THE STUDY AND
MONSTERING SLOWED DISEASE
PROGRESSION.
WITH ME TO TALK ABOUT THIS IS
HEATHER LAVOY, THE CHIEF
STRATEGY OFFICER WITH LLC IN
MANCHESTER.
>> THANK YOU FOR HAVING ME.
>> NICE TO HAVE YOU HERE.
WHAT LED THIS TO YOUR STUDY?
>> MORE THAN 8,000 INDIVIDUALS
EACH YEAR IN THIS COUNTRY ARE
TURNING AGE 65.
SO, WE KNOW THAT THERE CERTAINLY
AREN'T ENOUGH CARE GIVERS TO
TAKE CARE OF THEIR INDIVIDUALS
AND THAT POPULATION, ALSO, WANTS
TO BE ABLE TO CON HAVE A LESS AT
HOME.
--
AND THE HEALTH BURDEN, WE NEEDED
AN EFFECTIVE WAY TO HELP WITH
ADMISSIONS.
>> AND THE STUDY WAS DONE WITH
PATIENTS AT HOME WITH CHRONIC
DISEASE.
>> THAT'S CORRECT.
>> LET'S GO TO ONE OF THE
EXAMPLES, YOU CALL HIM
MR. JONES, HE'S 75 AND HE HAD
HEART FAILURE AND THE MOST
OBVIOUS QUESTION IS WHAT DID YOU
DO FOR HIM WITH THIS MONITORING?
LET'S SAY THAT THE VISITING
NURSE WOULDN'T DO?
>> SURE, WHAT WE WERE ABLE TO DO
IS ASSIGN CASE MANAGERS TO HELP
HIM WITH HIS CARE.
AND WE WENT OUT TO THE HOME TO
HELP EDUCATE HIM ON HOW TO USE
THE REMOTE MONITORING DEVICES.
WE DID ASSESSMENTS IN THE HOME
TO SEE CERTAINLY WHAT THE
PREVAILING DISEASES WERE AND
THEN ALSO WHAT WE MIGHT BE ABLE
TO DO TO HELP MITIGATE THAT.
SO HE HAD CHRONIC OBSTRUCTIVE
PULMONARY DISEASE.
HE HAD HEART FAILURE, DIABETES,
USING SUPPLEMENTAL OXYGEN.
IN THE HOME HE HAD OXYGEN WITH
CORDS RUNNING THROUGH THE HOUSE
WHICH PUT HIM AT RISK FOR FALL
AND ALSO COMPROMISED HIS HEALTH
IN WAYS THAT HE COULDN'T.
YOU KNOW, HIS QUALITY OF LIFE,
HE COULDN'T GO OUTSIDE ANYMORE,
SO WE WERE ABLE TO BRING SOME OF
OUR DEVICES INTO THE HOME.
>> AND YOU'VE GOT SOME DEVICES
WITH YOU THAT WERE KEY TO THIS
STUDY.
>> CORRECT.
>> HOLD THEM UP AND TELL ME WHAT
THEY ARE.
>> SURE.
THE FIRST IS A PATCH, THE ZEPHYR
PATCH AND THIS ACTUALLY MONITORS
RESPIRATION RATE AND IT DOES IT
TO LEAD E.
CAN G READING AND WE CAN
ACTUALLY DO THAT REMOTELY.
IT HAS AN ABBIN
AK
BBIN
N ABBING --
ACCELERATOR IN IT AND MEASURE
THEIR HEART RATE.
WE CAN SEE IF THEY'RE
COMPROMISED IN THEIR MOVEMENT,
CERTAINLY IN THEIR HEART RATE.
>> AND THAT'S SENT TO SMART
PHONE THAT HAS SPECIAL SOFTWARE.
>> THAT'S CORRECT.
SO WE HAVE A SMARTPHONE DEVICE
AND THE DATA TRANSMITS
WIRELESSLY TO THE DEVICE AND
ALSO TRANSMITS TO OUR NURSES,
WIRELESSLY AS WELL.
AND WE RUN CLINICAL ALGORITHMS
AND AS HIS CONDITIONS GO OUT OF
RANGE.
IT SETS TO THE NURSE AND DO
OUTREACH TO HELP INTERVENE AND
PROVIDE EDUCATION AND--
>> AND THAT'S SECURE.
>> THE DEVICES ARE REGULATED BY
THE F.D.A.
>> THE AMAZING THING.
IN SOME PATIENTS IT SLOWS
PROGRESSION OF THE DISEASE?
>> SIGNIFICANTLY AND WE DID A
FULL CONTROL STUDY AND WE SAW
THE PATIENTS IN THE POPULATION,
USING THE DEVICES AND MONITORING
REMOTELY AND THEIR DISEASE
PROGRESSION ACTUALLY WAS ALMOST
FLATTENED AND IT WAS ONLY 2%
INCREASE IN RISK AS COMPARED TO
THE CONTROL POPULATION, WHICH
WAS A COMPLETE MATCH OF THAT
POPULATION AND THEIR DISEASE
RISK WENT UP TO 31%.
>> WE'RE OUT OF TIME.
I KNOW THIS HAS BEEN USED IN
PENNSYLVANIA WHERE THE STUDY WAS
DONE, BUT IT WAS DONE BY TWO NEW
HAMPSHIRE COMPANIES, A COMPANY
IN MANCHESTER AND PORTSMOUTH AND
YOUR COMPANY IN MANCHESTER,
WHICH IS--
YOU'RE THE CHIEF STRATEGY
OFFICER.